In APCmin mice, PGE2 treatment increased tumor burden by promoting cell survival while deficiency of PPAR-δ showed the opposite effect; this may rely on the activation of PI3K/AKT/PPAR-δ signaling induced by PEG2 [89] (Figure 1J). This evidence concerns the gene PPARD and neoplasm.